@AntonioMyers 2 months ago
Biotech Breakthroughs: Betting on Cures or Chronic Care?
Biotech Breakthroughs: Betting on Cures or Chronic Care?
CRISPR Therapeutics vs. Amgen : one is pioneering gene-editing cures while the other dominates long-term biologics. If you had to choose a biotech play for the next decade, do you lean toward cutting-edge innovation or proven commercial scale?
There are no comments here, be the first to comment
